BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21033220)

  • 1. GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas.
    Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Sulkowski S
    Hepatogastroenterology; 2010; 57(101):741-5. PubMed ID: 21033220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
    Zhou YL; Deng CS
    Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
    Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
    Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
    Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
    J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
    Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
    Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose transporter GLUT1 in colorectal adenocarcinoma cell lines is inversely correlated with tumour cell proliferation.
    Hauptmann S; Grünewald V; Molls D; Schmitt WD; Köbel M; Kriese K; Schürmann A
    Anticancer Res; 2005; 25(5):3431-6. PubMed ID: 16101160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastases.
    Younes M; Lechago LV; Lechago J
    Clin Cancer Res; 1996 Jul; 2(7):1151-4. PubMed ID: 9816281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer.
    van Laarhoven HW; Kaanders JH; Lok J; Peeters WJ; Rijken PF; Wiering B; Ruers TJ; Punt CJ; Heerschap A; van der Kogel AJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):473-82. PubMed ID: 16242253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin kappa and immunoglobulin lambda are required for expression of the anti-apoptotic molecule Bcl-xL in human colorectal cancer tissue.
    Yang SB; Chen X; Wu BY; Wang MW; Cai CH; Cho DB; Chong J; Li P; Tang SG; Yang PC
    Scand J Gastroenterol; 2009; 44(12):1443-51. PubMed ID: 19883274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
    Tsushima H; Urata Y; Miyazaki Y; Fuchigami K; Kuriyama K; Kondo T; Tomonaga M
    Cell Growth Differ; 1997 Dec; 8(12):1317-28. PubMed ID: 9419420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-xL overexpression does not enhance specific erythropoietin productivity of recombinant CHO cells grown at 33 degrees C and 37 degrees C.
    Kim YG; Lee GM
    Biotechnol Prog; 2009; 25(1):252-6. PubMed ID: 19224599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL.
    Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H
    Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
    Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
    Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular prion protein promotes glucose uptake through the Fyn-HIF-2α-Glut1 pathway to support colorectal cancer cell survival.
    Li QQ; Sun YP; Ruan CP; Xu XY; Ge JH; He J; Xu ZD; Wang Q; Gao WC
    Cancer Sci; 2011 Feb; 102(2):400-6. PubMed ID: 21265952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
    Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of thymidylate synthase in human gastric and colorectal adenocarcinomas is upregulated by p16/INK4.
    Omura K; Uno Y; Kawakami K; Kanehira E; Tawaraya K; Tsukayama M; Hiranuma C; Watanabe Y
    Hepatogastroenterology; 2000; 47(33):742-5. PubMed ID: 10919023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and erythropoietin receptor in colorectal cancer.
    Chabowska AM; Sulkowska M; Chabowski A; Wincewicz A; Koda M; Sulkowski S
    Int J Surg Pathol; 2008 Jul; 16(3):269-76. PubMed ID: 18487221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of GLUT1 expression in adenocarcinoma and adenoma of the ampulla of Vater.
    Kim SJ; Lee HW; Kim DC; Rha SH; Hong SH; Jeong JS
    Pathol Int; 2008 Apr; 58(4):233-8. PubMed ID: 18324916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.
    Kondo E; Miyake T; Shibata M; Kimura T; Iwagaki H; Nakamura S; Tanaka T; Ohara N; Ichimura K; Oka T; Yanai H; Shibasaki F; Yoshino T
    Clin Cancer Res; 2005 Oct; 11(20):7255-63. PubMed ID: 16243795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.